Combined prednisolone and pirfenidone in bleomycin-induced lung disease
- 1 July 2016
- journal article
- case report
- Published by Wolters Kluwer Health in Journal of Cancer Research and Therapeutics
- Vol. 12 (3) , 1198-1202
Abstract
Bleomycin is a cytostatic drug commonly employed in the treatment of Hodgkin's disease, seminomas, and choriocarcinoma. Bleomycin may induce a chronic pulmonary inflammation that may progress to fibrosis. So far, only corticosteroids have been used in the treatment of bleomycin-induced lung disease with variable results. Pirfenidone is an antifibrotic drug that has been approved for the treatment of idiopathic pulmonary fibrosis. We report two cases of bleomycin-induced lung disease treated successfully with pirfenidone and oral corticosteroids.Keywords
This publication has 17 references indexed in Scilit:
- Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trialThe Lancet Respiratory Medicine, 2016
- Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosisThorax, 2016
- Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trialsBMJ Open Respiratory Research, 2016
- Landmark approvals in idiopathic pulmonary fibrosisNature Biotechnology, 2014
- Randomized Trial of Acetylcysteine in Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 2014
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trialsThe Lancet, 2011
- Antifibrotic action of pirfenidone and prednisolone: Different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosisEuropean Journal of Pharmacology, 2008
- Superoxide scavenging activity of pirfenidone–iron complexBiochemical and Biophysical Research Communications, 2008
- In vivo antioxidant treatment protects against bleomycin‐induced lung damage in ratsBritish Journal of Pharmacology, 2003
- Severe bleomycin lung toxicity: reversal with high dose corticosteroids.Thorax, 1993